OpGen Inc (OPGN): שווי כולל של נכסי החברה

OpGen, Inc. (OPGN) specializes in developing anti-infective agents, yet it is currently in a deep crisis, having effectively lost its influence within its niche. Major players have pushed the business out, and the competition for government contracts demands extreme analytical precision. Total assets amount to 0.00. This price chart illustrates capital dynamics against a backdrop of geopolitical risks and raw material logistics issues.

Amidst a critical weakening of its competitive position, OpGen, Inc. asset valuation currently stands at 0.00, reflecting total resources reverse-calculated via ROA as the sum of equity and debt. The trend of this indicator reveals management's inability to secure defensive financing, turning the growth of the asset base into a risk of increased debt load amid a total absence of market confidence.